Saturday, March 23, 2019
Home Tags Biotech

Tag: biotech

GW Pharma (NASDAQ:GWPH) Widening Loss Offsets Epidiolex Milestones

Shares of GW Pharmaceuticals (NASDAQ:GWPH) fell by 4% as the pharmaceutical company reported Q4 financial results that missed estimates. A wider than expected net...

XORTX Therapeutics Inc. (CNSX:XRX) Eyes Orphan Drug Designation

XORTX Therapeutics Inc. (CNSX:XRX) has achieved a significant milestone in the development of XRx-008. The drug treats autosomal dominant polycystic kidney disease (PKD). The...

Innovus Pharmaceuticals Inc. (OTCMKTS:INNV)’s Q3 Triggers $0.65 Target

Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) rebound from this year’s lows continued in Monday’s trading session. The stock was up by 10.8% as investors...

GLANCE TECHNOLOGIE (OTCMKTS:GLNNF) Targets Viral Adoption

GLANCE TECHNOLOGIE (OTCMKTS:GLNNF) GLANCE TECHNOLOGIE (OTCMKTS:GLNNF) shares gained 11.1% after the financial technology company unveiled a new version of its Glance Pay Merchant app. According to...

TITAN MEDICAL INC (OTCMKTS:TITXF) Drops After Pricing

TITAN MEDICAL INC (OTCMKTS:TITXF) Shares of TITAN MEDICAL INC (OTCMKTS:TITXF) fell 17.3% after the development stage company announced the pricing of previously announced marketed offerings....

Helius Medical Technologies Inc. (OTCMKTS:HSDT) Reports Positive Trial Results

Helius Medical Technologies Inc. (OTCMKTS:HSDT) Shares of Helius Medical Technologies Inc.(OTCMKTS:HSDT) fell 25.33% despite the company reporting positive results from its Registration Clinical trial for Traumatic...

Lexaria Bioscience Corp (OTCMKTS:LXRP) Spikes

Lexaria Bioscience Corp (OTCMKTS:LXRP) Lexaria Bioscience Corp (OTCMKTS:LXRP) was a big mover just days after the U.S Patent and Trademark Office granted it a new...

DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) Price Target At $5.20

DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) Shares of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) gained 7.01% after equity firm SeeThruEquity initiated coverage of the stock with a ‘buy’ rating....

Merck (NYSE:MRK) Acquires Stake In Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)

Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) Shares of Kalvista Pharmaceuticals (NASDAQ:KALV) gained 38.64% after the clinical-stage pharmaceutical company unveiled a collaboration pact with Merck & Co., Inc. (NYSE:MRK)....

UNIVEC, Inc. (OTCMKTS:UNVC) Explodes On AGRiMED Partnership

UNIVEC, Inc. (OTCMKTS:UNVC) UNIVEC, Inc. (OTCMKTS:UNVC) stock was a big mover after the specialty pharmaceutical company announced the signing a strategic partnership with AGRiMED. The...